Extracorporeal Membrane Oxygenation Market Share 2020, Research by Business Opportunities, Top Manufacturers and Global Forecast to 2025
Global Extracorporeal Membrane Oxygenation Market is valued at USD 311.1 Million in 2019 and expected to reach USD 416.9 Million by 2026 with a CAGR of 4.27% over the forecast period.
Increasing prevalence of cases of cardiopulmonary disease and respiratory failure is driving the extracorporeal membrane oxygenation market
Get Sample of This [email protected] https://brandessenceresearch.com/requestSample/PostId/1148
Scope of Global Extracorporeal Membrane Oxygenation Market Report–
Extracorporeal membrane oxygenation (ECMO), also called as extracorporeal life support (ECLS), is an extracorporeal technique of providing continued cardiac and respiratory support to patients whose heart and lungs are incapable to provide require amount of gas exchange to sustain life. The technology is derived from cardiopulmonary bypass. ECMO’s working concept is to temporarily drawing blood from body to enable artificial oxygenation of red blood cells and removal of carbon dioxide. It is mainly used in post-cardiopulmonary bypass or in treatment of patient with profound heart and lung failure. Recently, it is being used in treatment of COVID-19 patients where artificial ventilation is not sufficient to maintain blood oxygenation level.
Global Extracorporeal Membrane Oxygenation Market is segmented on the basis of modality, application, and region & country level. Based on modality, global extracorporeal membrane oxygenation market is classified as Venoarterial (VA), Venovenous (VV) and Arteriovenous (AV). Based upon application, global extracorporeal membrane oxygenation market is classified into respiratory, cardiac and extracorporeal cardiopulmonary resuscitation (ECPR)
Some major key players for global extracorporeal membrane oxygenation market are,
XENIOS AG, Terumo Corporation, MicroPort Scientific Corporation, NIPRO Corporation, OriGen Biomedical, Inc, ALung Technologies, Inc., EUROSETS S.r.l. Medtronic Plc., Sorin Group, MAQUET Holding B.V. & Co. KG, Medos Medizintechnik AG, Others
The regions covered in this extracorporeal membrane oxygenation market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of extracorporeal membrane oxygenation is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Extracorporeal Membrane Oxygenation Market Segmentation:–
By Modality: Venoarterial (VA), Venovenous (VV), Arteriovenous (AV)
By Application: Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitation (ECPR)
Global Extracorporeal Membrane Oxygenation Market Dynamics–
Major factor driving the extracorporeal membrane oxygenation market is growing cases of cardiopulmonary disease and respiratory failure. For instance; cardiovascular diseases (CVD) are number one cause of death worldwide according to World Health Organization (WHO) and almost 17.9 million people died from CVDs in 2016 which was 31% of all global deaths. The prevalence of CVDs also increases the demand of ECMO as it helps in treatment of this disease. As per European Respiratory Society; approximately 65 million people suffer from chronic obstructive pulmonary disease (COPD) and 3 million die each year. The prevalence of COPD also helps in increasing business of ECMO. At present, ECMO has become more dependable on the advancement in equipment and increased experience of professionals such as application of it as bridge to transplant, both for cardiac & lung and support for lung resections in unstable patients. According to annual international ELSO registry report, more than 65,171 patients were treated with extracorporeal life support (ECLS) form which 53% are new born, 25% were pediatric and 23% were adults. It shows the increasing use of ECMO in respiratory problem cases.
Global Extracorporeal Membrane Oxygenation Market Regional Analysis–
North America is dominating the global ECMO market with highest market share due to presence of major players, investment in research & development and prevalence of diseases in this region. For instance; from 2014 to 2015, heart disease costs about USD 219 billion in USA, which also affects the ECMO market, as many patients are able to bear the high cost of treatment through ECMO. According to a registry run by the Extracorporeal Life Support Organization (ELSO); the number of U.S. hospitals providing ECMO has more than doubled from 108 in 2008 to 264 in 2019.
About us: Brandessence Market Research and Consulting Pvt. Ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals, and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations, and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at [email protected]